GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Initiator Pharma AS (OSTO:INIT) » Definitions » EPS (Basic)

Initiator Pharma AS (OSTO:INIT) EPS (Basic) : kr-0.33 (TTM As of Mar. 2025)


View and export this data going back to 2017. Start your Free Trial

What is Initiator Pharma AS EPS (Basic)?

Initiator Pharma AS's basic earnings per share (Basic EPS) for the three months ended in Mar. 2025 was kr-0.07. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2025 was kr-0.33.

Initiator Pharma AS's EPS (Diluted) for the three months ended in Mar. 2025 was kr-0.07. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 was kr-0.33.

Initiator Pharma AS's EPS without NRI for the three months ended in Mar. 2025 was kr-0.07. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2025 was -0.33.

During the past 3 years, the average EPS without NRI Growth Rate was 24.30% per year. During the past 5 years, the average EPS without NRI Growth Rate was -1.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 9 years, Initiator Pharma AS's highest 3-Year average EPS without NRI Growth Rate was 44.80% per year. The lowest was -62.50% per year. And the median was -11.60% per year.


Initiator Pharma AS EPS (Basic) Historical Data

The historical data trend for Initiator Pharma AS's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Initiator Pharma AS EPS (Basic) Chart

Initiator Pharma AS Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EPS (Basic)
Get a 7-Day Free Trial Premium Member Only -0.43 -0.83 -1.18 -0.66 -0.36

Initiator Pharma AS Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.12 -0.14 -0.09 -0.03 -0.07

Initiator Pharma AS EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Initiator Pharma AS's Basic EPS for the fiscal year that ended in Dec. 2024 is calculated as

Basic EPS (A: Dec. 2024 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-19.946-0)/55.625
=-0.36

Initiator Pharma AS's Basic EPS for the quarter that ended in Mar. 2025 is calculated as

Basic EPS (Q: Mar. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-3.896-0)/56.158
=-0.07

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-0.33

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Initiator Pharma AS  (OSTO:INIT) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Initiator Pharma AS EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Initiator Pharma AS's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.


Initiator Pharma AS Business Description

Traded in Other Exchanges
N/A
Address
Co/ COBIS, Ole Maaloesvej 3, Copenhagen, DNK, 2200
Initiator Pharma AS is a research and development company engaged in the pharmaceutical development of drugs to be used for erectile dysfunction, depression, and pain. It Research is focused in the area of monoamine reuptake inhibitors.

Initiator Pharma AS Headlines

No Headlines